Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
2006 3
2007 1
2008 2
2009 3
2010 8
2011 8
2012 16
2013 10
2014 5
2015 4
2016 3
2017 3
2018 5
2019 7
2020 9
2021 10
2022 10
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial.
Ohba A, Morizane C, Ueno M, Kobayashi S, Kawamoto Y, Komatsu Y, Ikeda M, Sasaki M, Okano N, Furuse J, Hiraoka N, Yoshida H, Kuchiba A, Sadachi R, Nakamura K, Matsui N, Nakamura Y, Okamoto W, Yoshino T, Okusaka T. Ohba A, et al. Among authors: kuchiba a. Future Oncol. 2022 Jun;18(19):2351-2360. doi: 10.2217/fon-2022-0214. Epub 2022 May 5. Future Oncol. 2022. PMID: 35510484 Free article.
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910.
Shida D, Kuchiba A, Shibata T, Hamaguchi T, Yamasaki S, Ito M, Kobatake T, Tonooka T, Masaki T, Shiozawa M, Takii Y, Uetake H, Okamura S, Ojima H, Kazama S, Takeyama H, Kanato K, Shimada Y, Murakami Y, Kanemitsu Y. Shida D, et al. Among authors: kuchiba a. Cancer Sci. 2023 Aug;114(8):3352-3363. doi: 10.1111/cas.15834. Epub 2023 May 15. Cancer Sci. 2023. PMID: 37189003 Free PMC article.
Interactive assistance via eHealth for small- and medium-sized enterprises' employer and health care manager teams on tobacco control (eSMART-TC): protocol for a cluster randomized hybrid type II trial (N-EQUITY2101/J-SUPPORT2102).
Saito J, Odawara M, Fujimori M, Kuchiba A, Oyamada S, Swe KT, Saito E, Fukai K, Tatemichi M, Nakamura M, Uchitomi Y, Shimazu T. Saito J, et al. Among authors: kuchiba a. Implement Sci Commun. 2023 Jun 7;4(1):61. doi: 10.1186/s43058-023-00444-0. Implement Sci Commun. 2023. PMID: 37287041 Free PMC article.
Statistical methods for studying disease subtype heterogeneity.
Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, Poole EM, Tamimi R, Tworoger SS, Giovannucci E, Rosner B, Ogino S. Wang M, et al. Among authors: kuchiba a. Stat Med. 2016 Feb 28;35(5):782-800. doi: 10.1002/sim.6793. Epub 2015 Dec 1. Stat Med. 2016. PMID: 26619806 Free PMC article.
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients.
Higashiyama RI, Horinouchi H, Kuchiba A, Matsumoto Y, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y. Higashiyama RI, et al. Among authors: kuchiba a. J Cancer Res Clin Oncol. 2023 Jul;149(7):3185-3191. doi: 10.1007/s00432-022-04205-9. Epub 2022 Jul 28. J Cancer Res Clin Oncol. 2023. PMID: 35900471 Free PMC article. Review.
104 results